Health Condition 1: K810- Acute cholecystitis Health Condition 2: K812- Acute cholecystitis with chronic cholecystitis Health Condition 3: K811- Chronic cholecystitis Health Condition 4: K819- Cholecystitis, unspecified Health Condition 5: K800- Calculus of gallbladder with acutecholecystitis Health Condition 6: K801- Calculus of gallbladder with othercholecystitis Health Condition 7: K802- Calculus of gallbladder without cholecystitis Health Condition 8: K804- Calculus of bile duct with cholecy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: American society of anaesthesiologists ASA physical status 1 and 2 weight 40kg to 70kg
Exclusion criteria
Exclusion criteria: Patient refusal Patients with known allergy to study drug Patients coming for any emergency surgeries Patient with history of motion sickness or dizziness or vestibular disease Known prolactin dependent tumour or phaeochromocytoma Documented clinically significant cardiac arrythmia or long QT syndrome Pregnant or breastfeeding History of epilepsy, parkinsons, treatment with levodopa Received any emetogenic anticancer therapy in previous 4 weeks Pre existing nausea or vomiting in the 24 hours before surgery Patients being treated with regular antiemetic therapy including systemic corticosteroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the incidence of postoperative nausea and vomiting following premedication with amisulpride and ondansetron in patients undergoing laparoscopic cholecystectomyTimepoint: Nausea and vomiting assessed postoperatively at the following time points 2hours after surgery 6 hours after surgery 12 hours after surgery 24 hours after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
MS Ramaiah Medical College